It takes 10 years and a billion dollars to develop a drug candidate ready for clinical trials. Despite such investments, the overall success of drugs in clinical trials is only 7.9%. Improving both the candidate selection process along with the matching of appropriate companion devices, can immensely improve the chances of success. It also improves the chances of repurposing such candidates if trials ultimately fail. OnTarget technology platform enables a smarter approach to both the drug candidate and clinical trial participant selection.